Top Markets
#1 Velas Velas +480.89%
#2 NEW X CEO IS BACK NEW X CEO IS BACK +109.20%
#3 Siren Siren +107.10%
#4 Scor Scor +32.34%
#5 Ontology Ontology +28.94%
#6 Black Phoenix Black Phoenix +18.50%
#7 Venom Venom +16.43%
#8 BNB Attestation Service BNB Attestation Service +13.39%
#9 Osaka Protocol Osaka Protocol +12.54%
#10 Cetus Protocol Cetus Protocol +10.08%
Coin of the day
Velas Velas
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Novartis AG Novartis AG

Novartis AG

NVS
Rang in Aktien #43
Novartis AG researches, develops, manufactures, and markets healthcare products... Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Aktienkurs
$148.18
Marktkapitalisierung
$286.44B
Veränderung (1 Tag)
-1.02%
Veränderung (1 Jahr)
38.23%
Land
CH
Handel Novartis AG (NVS)

Kategorie

Healthcare
Dividendenhistorie für Novartis AG (NVS)
Novartis AG (Aktienkürzel: NVS) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Novartis AG (NVS) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
215.00%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
67.00%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US